[Drug addiction and withdrawal].
Tacke
U
U
National Addiction Centre, Institute of Psychiatry, De Crespigny Park, London, England.
Kuoppasalmi
K
K
Airaksinen
M
M
D001569:Benzodiazepines / Q000009:adverse effects / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002188:Cannabis / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000494:pharmacology; D003695:Delivery of Health Care / Q000458:organization & administration; D004298:Dopamine / Q000378:metabolism; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D013287:Illicit Drugs; D009294:Narcotics / Q000009:adverse effects / Q000494:pharmacology; D009538:Nicotine / Q000009:adverse effects / Q000494:pharmacology; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D010623:Phencyclidine Abuse / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology
D000697:Central Nervous System Stimulants; D013287:Illicit Drugs; D009294:Narcotics; D001569:Benzodiazepines; D009538:Nicotine; D004298:Dopamine
Lääkeriippuvuus ja vieroittaminen.